Generation Bio's Series A Round

Generation Bio raised a round of funding on January 01, 2016. Investors include Atlas Venture.

Generation Bio aims to deliver titratable, re-dosable genetic medicines with drug-like properties to patients with a wide range of genetic diseases.…

Articles about Generation Bio's Series A Round: